FGF23 and chronic kidney disease: In patients affected with chronic kidney disease (CKD), serum PTH increases due to a complex pathophysiological mechanism involving phosphorus (P), Fibroblast Growth Factor−23 (FGF-23), vitamin D metabolites and iCa [2].